Completed NA INTERVENTIONAL 1-arm NCT01484288

Baroreflex Activation Therapy in Heart Failure

Sponsor: CVRx, Inc.

Updated 10 times since 2017 Last updated: Aug 3, 2021 Started: Nov 30, 2011 Primary completion: Jul 31, 2013 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01484288, this NA trial focuses on Heart Failure and remains completed. Sponsored by CVRx, Inc., it has been updated 10 times since 2011, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Sep 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 5 earlier versions

Jan 2021 — Sep 2021 [monthly]

Completed NA
Aug 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Aug 2019 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CVRx, Inc.

Data source: CVRx, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy